A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy

D Cocito, I Paolasso, G Antonini, L Benedetti, C Briani, C Comi, R Fazio, S Jann, S Matà, A Mazzeo, Mario Sabatelli, E. Nobile Orazio

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

The guidelines for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) therapy suggest to use immunoglobulins (IVIg) and steroid as first-line therapies. Patients who do not respond to one of the two drugs should be switched to the other drug. We collected therapeutic outcome data in patients followed at 11 centres in order to document the clinical practice in Italy.
Original languageEnglish
Pages (from-to)289-294
Number of pages6
JournalEuropean Journal of Neurology
Volume17
DOIs
Publication statusPublished - 2010

Keywords

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Databases, Factual
  • Humans
  • Immunoglobulins, Intravenous
  • Immunologic Factors
  • Immunotherapy
  • Italy
  • Middle Aged
  • Plasma Exchange
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
  • Registries
  • Retrospective Studies
  • Steroids
  • Treatment Outcome
  • Young Adult

Fingerprint

Dive into the research topics of 'A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy'. Together they form a unique fingerprint.

Cite this